Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur M. K. HAHN |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
Choline transporter gene variation is associated with attention-deficit hyperactivity disorder / B. A. ENGLISH in Journal of Neurodevelopmental Disorders, 1-4 (December 2009)
[article]
Titre : Choline transporter gene variation is associated with attention-deficit hyperactivity disorder Type de document : Texte imprimé et/ou numérique Auteurs : B. A. ENGLISH, Auteur ; M. K. HAHN, Auteur ; I. R. GIZER, Auteur ; M. MAZEI-ROBISON, Auteur ; A. STEELE, Auteur ; D. M. KURNIK, Auteur ; M. A. STEIN, Auteur ; Irwin D. WALDMAN, Auteur ; R. D. BLAKELY, Auteur Article en page(s) : p.252-63 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : The neurotransmitter acetylcholine (ACh) plays a critical role in brain circuits mediating motor control, attention, learning and memory. Cholinergic dysfunction is associated with multiple brain disorders including Alzheimer's Disease, addiction, schizophrenia and Attention-Deficit Hyperactivity Disorder (ADHD). The presynaptic choline transporter (CHT, SLC5A7) is the major, rate-limiting determinant of ACh production in the brain and periphery and is consequently upregulated during tasks that require sustained attention. Given the contribution of central cholinergic circuits to the control of movement and attention, we hypothesized that functional CHT gene variants might impact risk for ADHD. We performed a case-control study, followed by family-based association tests on a separate cohort, of two purportedly functional CHT polymorphisms (coding variant Ile89Val (rs1013940) and a genomic SNP 3' of the CHT gene (rs333229), affording both a replication sample and opportunities to reduce potential population stratification biases. Initial genotyping of pediatric ADHD subjects for two purportedly functional CHT alleles revealed a 2-3 fold elevation of the Val89 allele (n = 100; P = 0.02) relative to healthy controls, as well as a significant decrease of the 3'SNP minor allele in Caucasian male subjects (n = 60; P = 0.004). In family based association tests, we found significant overtransmission of the Val89 variant to children with a Combined subtype diagnosis (OR = 3.16; P = 0.01), with an increased Odds Ratio for a haplotype comprising both minor alleles. These studies show evidence of cholinergic deficits in ADHD, particularly for subjects with the Combined subtype, and, if replicated, may encourage further consideration of cholinergic agonist therapy in the disorder. En ligne : http://dx.doi.org/10.1007/s11689-009-9033-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=341
in Journal of Neurodevelopmental Disorders > 1-4 (December 2009) . - p.252-63[article] Choline transporter gene variation is associated with attention-deficit hyperactivity disorder [Texte imprimé et/ou numérique] / B. A. ENGLISH, Auteur ; M. K. HAHN, Auteur ; I. R. GIZER, Auteur ; M. MAZEI-ROBISON, Auteur ; A. STEELE, Auteur ; D. M. KURNIK, Auteur ; M. A. STEIN, Auteur ; Irwin D. WALDMAN, Auteur ; R. D. BLAKELY, Auteur . - p.252-63.
Langues : Anglais (eng)
in Journal of Neurodevelopmental Disorders > 1-4 (December 2009) . - p.252-63
Index. décimale : PER Périodiques Résumé : The neurotransmitter acetylcholine (ACh) plays a critical role in brain circuits mediating motor control, attention, learning and memory. Cholinergic dysfunction is associated with multiple brain disorders including Alzheimer's Disease, addiction, schizophrenia and Attention-Deficit Hyperactivity Disorder (ADHD). The presynaptic choline transporter (CHT, SLC5A7) is the major, rate-limiting determinant of ACh production in the brain and periphery and is consequently upregulated during tasks that require sustained attention. Given the contribution of central cholinergic circuits to the control of movement and attention, we hypothesized that functional CHT gene variants might impact risk for ADHD. We performed a case-control study, followed by family-based association tests on a separate cohort, of two purportedly functional CHT polymorphisms (coding variant Ile89Val (rs1013940) and a genomic SNP 3' of the CHT gene (rs333229), affording both a replication sample and opportunities to reduce potential population stratification biases. Initial genotyping of pediatric ADHD subjects for two purportedly functional CHT alleles revealed a 2-3 fold elevation of the Val89 allele (n = 100; P = 0.02) relative to healthy controls, as well as a significant decrease of the 3'SNP minor allele in Caucasian male subjects (n = 60; P = 0.004). In family based association tests, we found significant overtransmission of the Val89 variant to children with a Combined subtype diagnosis (OR = 3.16; P = 0.01), with an increased Odds Ratio for a haplotype comprising both minor alleles. These studies show evidence of cholinergic deficits in ADHD, particularly for subjects with the Combined subtype, and, if replicated, may encourage further consideration of cholinergic agonist therapy in the disorder. En ligne : http://dx.doi.org/10.1007/s11689-009-9033-8 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=341